The predictive value of global longitudinal strain for Serum Natriuretic Peptide and in-hospital outcome:

a prospective study in acute heart failure

Predictors of early death in high risk acute heart failure patients treated with levosimendan

Predicting non-invasive ventilation failure in acute heart failure patients presenting in the emergency
department

NurCahya775537

nurcahyakuswardhana@gmail.com

Indications for cardiac resynchronisation therapy in heart failure with conventional pacemaker
indications

Indications for pacing

Indications for cardiac resynchronisation therapy in atrial fibrillation

Indication for cardiac resynchronisation therapy in sinus rhythm

2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting
Without Persistent ST-Segment Elevation - Part 1 –

2016 ESC Guidelines for the management of atrial fibrillation developed in cooperation
with EACTS
2019 ESC Supraventricular Tachycardias
Supraventricular tachycardia (non-AF) - Pathophysiology and mechanisms

State-of-the-art lecture: optimal management of antithrombotic therapy in critically ill

patients
Pearls on cardiogenic shock diagnosis and management. The North American perspective
Can heart failure medications be stopped after normalization of ejection fraction?
Suboptimal prescription of beta-blockers at discharge in patients with st elevation
myocardial infarction
Effect of beta-blocker dose on the prognosis in chronic heart failure patients depending on
the presence of atrial fibrillation. Data from FAR NHL (FARmacology and
NeuroHumoraL activation) registry
Congenital Long QT Syndromes: clinical aspects and management advice
Long-term prognostic impact of beta-blocker prescription during hospitalization for acute
myocardial infarction
Can beta-blockers be terminated post-MI? - Who really needs them and how long

Beta-blockers in diabetes with stable coronary heart disease- a cause for concern
CLARIFY - First-line anti-ischemic agents use and long-term clinical outcomes in stable
coronary artery disease
Characteristics of heart failure patients treated with sacubitril/valsartan in the province of
Quebec, Canada
Association between heart failure medication at discharge and heart failure readmission
Patient's awareness of Idarucizumab and subsequent preference over anticoagulation

Left ventricular assist devices improve pulmonary hemodynamics in bridge to transplant

patients with end stage heart failure

²-Blocker Therapy in Heart Failure: Scientific Review